1) Primary and secondary carnitine deficiency
\nMyocardial metabolic disorders due to ischemic heart disease: angina pectoris, acute myocardial infarction
\nAdults: Intramuscular injection or IV drip of 2~3g L-carnitine per day, divided into 2 or 3 doses.
\nIncrease or decrease the administered amount according to age and symptoms.
\n2) Treatment of carnitine deficiency in end-stage renal disease patients undergoing hemodialysis
\nInitially, 10-20mg\/kg is administered intravenously over a 2?3-minute period at the end of each hemodialysis.
\nHowever, the dosage can be adjusted in accordance with the plasma L-carnitine level before hemodialysis.<\/p>\n
Store in an opaque sealed container at room temperature (1~30\u2103)<\/p>\n
Ingredient: L-Carnitine 0.2g\/5mL<\/p>\n","protected":false},"excerpt":{"rendered":"
1) Primary and secondary carnitine deficiency Myocardial metabolic disorders due to ischemic heart disease: angina pectoris, acute myocardial infarction Adults: Intramuscular injection or IV drip of 2~3g L-carnitine per day, divided into 2 or 3 doses. Increase or decrease the administered amount according to age and symptoms. 2) Treatment of carnitine deficiency in end-stage renal …<\/p>\n